OVITZ CORPORATION

Medtech · Private

Commercial aberrometer (xwave) and proprietary ML-automated algorithm for designing custom scleral lenses with higher-order aberration optics

Grants
$306K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
25
4 granted · 21 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · AI-Driven Tools for Automated Design of Higher Order Aberration Optics in Contact Lenses$306,171
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2001FREYYA, INC.——
2002Autonomix Medical, Inc.—$8.9M
2003Newmark Diagnostics LLC——
2004OVITZ CORPORATION——
2005JAVELIN BIOTECH INC——
2006SANAHEAL, INC.——
2007NANONERVE, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 4 granted of 25

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.